How to differentiate induced pluripotent stem cells into sensory neurons for disease modelling: a functional assessment
Anil Kumar Kalia,Corinna Rösseler,Rafael Granja-Vazquez,Ayesha Ahmad,Joseph J. Pancrazio,Anika Neureiter,Mei Zhang,Daniel Sauter,Irina Vetter,Asa Andersson,Gregory Dussor,Theodore J. Price,Benedict J. Kolber,Vincent Truong,Patrick Walsh,Angelika Lampert
DOI: https://doi.org/10.1186/s13287-024-03696-2
2024-04-06
Stem Cell Research & Therapy
Abstract:Human induced pluripotent stem cell (iPSC)-derived peripheral sensory neurons present a valuable tool to model human diseases and are a source for applications in drug discovery and regenerative medicine. Clinically, peripheral sensory neuropathies can result in maladies ranging from a complete loss of pain to severe painful neuropathic disorders. Sensory neurons are located in the dorsal root ganglion and are comprised of functionally diverse neuronal types. Low efficiency, reproducibility concerns, variations arising due to genetic factors and time needed to generate functionally mature neuronal populations from iPSCs remain key challenges to study human nociception in vitro. Here, we report a detailed functional characterization of iPSC-derived sensory neurons with an accelerated differentiation protocol ("Anatomic" protocol) compared to the most commonly used small molecule approach ("Chambers" protocol). Anatomic's commercially available RealDRGTM were further characterized for both functional and expression phenotyping of key nociceptor markers.
cell biology,medicine, research & experimental,cell & tissue engineering